DailyStocks Stock Article Search

https://www.zacks.com/commentary/2206233/3-retail-pharmacy-drugstore-stocks-to-watch-amid-industry-headwinds?cid=CS-ZC-FT-industry_outlook-2206233 Jan 05, 2024 - Zacks Retail-Pharmacies and Drug Stores industry players like CVS, HLF and RADCQ are likely to gain despite reimbursement challenges that are hurting the overall industry health. 0

https://www.zacks.com/stock/news/2205902/here-s-why-cvs-health-cvs-fell-more-than-broader-market?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2205902 Jan 04, 2024 - CVS Health (CVS) closed the most recent trading day at $80.51, moving -0.46% from the previous trading session. 0

https://www.zacks.com/stock/news/2205591/cvs-health-corporation-cvs-is-attracting-investor-attention-here-is-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|most_searched_stocks-2205591 Jan 04, 2024 - Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. 0

https://seekingalpha.com/news/4052170-cvs-to-drop-humira-from-certain-formularies-cover-biosimilars-instead?source=feed_sector_healthcare Jan 03, 2024 - CVS Health (CVS) said that its Caremark unit will remove AbbVie’s (ABBV) blockbuster drug Humira from its major national commercial formularies on April 1 and c 0

https://www.zacks.com/stock/news/2203894/cvs-health-cvs-stock-moves-0-01-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2203894 Dec 29, 2023 - CVS Health (CVS) closed the most recent trading day at $78.96, moving -0.01% from the previous trading session. 0

https://www.zacks.com/stock/news/2202694/here-s-why-you-should-retain-cvs-health-cvs-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2202694 Dec 27, 2023 - Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan. 0

https://www.cnbc.com/2023/12/22/health-sector-themes-to-watch-in-2024.html Dec 22, 2023 - The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have positive momentum in 2024. 0

https://www.zacks.com/stock/news/2201251/cvs-health-cvs-surpasses-market-returns-some-facts-worth-knowing?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2201251 Dec 21, 2023 - In the closing of the recent trading day, CVS Health (CVS) stood at $78.62, denoting a +1.79% change from the preceding trading day. 0

https://www.zacks.com/stock/news/2199941/should-you-invest-in-cvs-health-cvs-based-on-bullish-wall-street-views?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2199941 Dec 19, 2023 - Based on the average brokerage recommendation (ABR), CVS Health (CVS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2199865/cvs-health-cvs-new-opportunities-drive-growth-macro-woes-stay?cid=CS-ZC-FT-analyst_blog|zer_report_update-2199865 Dec 19, 2023 - CVS Health's (CVS) restructuring plan poises it well, along with its strategic buyouts. 0